Completed PHASE2 INTERVENTIONAL 2-arm NCT00210132

Analgesic Efficacy of Inter Pleural Ropivacaine Road in Post Thoracotomy Pain for Oncologic Surgery (ROPAL-1)

Randomized Trial to Evaluate the Analgesic Efficacy of Inter Pleural Ropivacaine Road in Post Thoracotomy Pain for Oncologic Surgery

Sponsor: Institut Bergonié

Conditions Cancer Postoperative Pain

Interventions Reference Ropivacaine

Updated 6 times since 2017 Last updated: Aug 20, 2025 Started: Oct 1, 2003 Primary completion: Jun 30, 2006 Completion: Feb 28, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Cancer and Postoperative Pain and is currently completed. Institut Bergonié leads this study, which shows 6 recorded versions since 2003 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Oct 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Oct 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Oct 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Institut Bergonié

Data source: Institut Bergonié

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bordeaux, France